Growing community of inventors

Laval, Canada

Pierre Du Ruisseau

Average Co-Inventor Count = 5.26

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 65

Pierre Du RuisseauPhil Gold (4 patents)Pierre Du RuisseauUri H Saragovi (4 patents)Pierre Du RuisseauClaudio A Cuello (4 patents)Pierre Du RuisseauSerge Moffett (3 patents)Pierre Du RuisseauNicole Bernard (3 patents)Pierre Du RuisseauChandra J Panchal (1 patent)Pierre Du RuisseauSerge Moffet (1 patent)Pierre Du RuisseauJonathan Reeves (1 patent)Pierre Du RuisseauEdward Jerome Tanner (1 patent)Pierre Du RuisseauPierre Du Ruisseau (5 patents)Phil GoldPhil Gold (10 patents)Uri H SaragoviUri H Saragovi (6 patents)Claudio A CuelloClaudio A Cuello (6 patents)Serge MoffettSerge Moffett (9 patents)Nicole BernardNicole Bernard (3 patents)Chandra J PanchalChandra J Panchal (4 patents)Serge MoffetSerge Moffet (1 patent)Jonathan ReevesJonathan Reeves (1 patent)Edward Jerome TannerEdward Jerome Tanner (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Proscan Rx Pharma Inc. (4 from 5 patents)

2. Ambrilia Biopharma, Inc. (1 from 6 patents)


5 patents:

1. 8512702 - Prostate cancer diagnosis and treatment

2. 8101713 - Prostate cancer diagnosis and treatment

3. 7910693 - Prostate cancer diagnosis and treatment

4. 7811564 - Prostate cancer diagnosis and treatment

5. 7534580 - PSP94 diagnostic reagents and assays

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/5/2026
Loading…